The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 24, 2020
Filed:
Aug. 09, 2016
Applicants:
Massachusetts Institute of Technology, Cambridge, MA (US);
Dalhousie University, Halifax, CA;
Inventors:
Mark Firman Bear, Boston, MA (US);
Kevin R. Duffy, Bible Hill, CA;
Donald E. Mitchell, Halifax, CA;
Ming-Fai Fong, Cambridge, MA (US);
Arnold Heynen, Providence, RI (US);
Jeffrey P. Gavornik, Cambridge, MA (US);
Assignee:
Massachusetts Institute of Technology, Cambridge, MA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/529 (2006.01); A61K 9/00 (2006.01); A61K 31/4409 (2006.01); A61K 31/381 (2006.01); A61K 31/4168 (2006.01); A61K 31/137 (2006.01); A61K 31/245 (2006.01); A61K 31/47 (2006.01); A61K 31/167 (2006.01); A61K 31/445 (2006.01); A61K 31/4174 (2006.01); A61K 38/48 (2006.01); A61K 45/06 (2006.01); A61K 31/46 (2006.01); A61K 31/216 (2006.01);
U.S. Cl.
CPC ...
A61K 31/529 (2013.01); A61K 9/0048 (2013.01); A61K 31/137 (2013.01); A61K 31/167 (2013.01); A61K 31/216 (2013.01); A61K 31/245 (2013.01); A61K 31/381 (2013.01); A61K 31/4168 (2013.01); A61K 31/4174 (2013.01); A61K 31/445 (2013.01); A61K 31/4409 (2013.01); A61K 31/46 (2013.01); A61K 31/47 (2013.01); A61K 38/4893 (2013.01); A61K 45/06 (2013.01);
Abstract
Amblyopia is a prevalent form of visual impairment that generally arises during infancy and early childhood when inputs to the visual cortex form the two eyes are poorly balanced. Disclosed herein are methods involving retinal inactivation of at least one retina to treat visual impairment in the form of amblyopia or other conditions.